Skip to main content
Back
Watch Compare

Outset Medical, Inc.

Data quality: 100%
OM
Nasdaq Manufacturing Measuring & Analyzing Instruments
$4.27
▲ $0.07 (1.76%)
Mkt Cap: 78.26 M
Price
$4.27
Mkt Cap
78.26 M
Day Range
$4.08 — $4.33
52-Week Range
$3.00 — $21.98
Volume
45,412
Open $4.16
50D / 200D Avg
$3.88
10.06% above
50D / 200D Avg
$9.81
56.44% below

Quick Summary

Key Takeaways

Revenue grew 3.88% annually over 5 years — modest growth
Negative free cash flow of -47.13 M
Capital efficient — spends only 0.67% of revenue on capex

Growth

Revenue Growth (5Y)
3.88%
Above sector avg (1.82%)
Revenue (1Y)5.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-54.96%
Below sector avg (-53.41%)
ROIC-21.43%
Net Margin-68.34%
Op. Margin-55.83%

Safety

Debt / Equity
0.67
Above sector avg (0.31)
Current Ratio7.09
Interest Coverage-4.78

Valuation

PE (TTM)
-0.96
Above sector avg (-1.48)
P/B Ratio0.55
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -1.0 -1.5
P/B 0.6 1.6
ROE % -55.0 -53.4
Net Margin % -68.3 -41.5
Rev Growth 5Y % 3.9 1.8
D/E 0.7 0.3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0.00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 5.09% Revenue Growth (3Y) -4.27%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3.88% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 119.48 M Net Income (TTM) -81.65 M
ROE -54.96% ROA -28.85%
Gross Margin 39.13% Operating Margin -55.83%
Net Margin -68.34% Free Cash Flow (TTM) -47.13 M
ROIC -21.43% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.67 Current Ratio 7.09
Interest Coverage -4.78 Asset Turnover 0.42
Working Capital 227.92 M Tangible Book Value 142.37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.96 Forward P/E N/A
P/B Ratio 0.55 P/S Ratio 0.66
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -60.22%
Market Cap 78.26 M Enterprise Value 137.35 M
Per Share
EPS (Diluted TTM) -5.37 Revenue / Share 6.53
FCF / Share -2.57 OCF / Share -2.53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.67% FCF Conversion 57.71%
SBC-Adj. FCF -65.07 M Growth Momentum 1.21

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 119.48 M 113.69 M 130.38 M 115.38 M 102.60 M
Net Income -81.65 M -127.98 M -172.80 M -162.96 M -131.94 M
EPS (Diluted) -5.37 -2.46 -3.48 -3.38 —
Gross Profit 46.75 M 38.56 M 29.00 M 17.83 M 7.61 M
Operating Income -66.71 M -113.38 M -169.77 M -161.02 M -130.52 M
EBITDA — — — — —
R&D Expenses 21.24 M 38.40 M 57.31 M 48.86 M 36.74 M
SG&A Expenses — — — — —
D&A 4.34 M 5.73 M 5.81 M 5.17 M 5.16 M
Interest Expense 13.95 M 23.87 M 12.68 M 3.57 M 1.72 M
Income Tax 718,000.0 491,000.0 523,000.0 295,000.0 199,000.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 264.50 M 275.80 M 313.80 M 400.12 M 463.46 M
Total Liabilities 137.54 M 248.98 M 190.92 M 154.13 M 89.38 M
Shareholders' Equity 126.95 M 26.82 M 122.89 M 245.99 M 374.08 M
Total Debt 96.24 M 197.38 M 130.11 M 96.34 M 29.76 M
Cash & Equivalents 35.01 M 124.01 M 68.51 M 73.22 M 182.35 M
Current Assets 250.88 M 258.22 M 291.22 M 373.65 M 409.80 M
Current Liabilities 37.63 M 45.38 M 55.32 M 51.95 M 51.70 M